Dissecting the potential role of ferroptosis in liver diseases: an updated review

References

• Shojaie L, Iorga A, Dara L. Cell death in liver diseases: a review. Int J Mol Sci. 2020;21(24):9682. doi: 10.3390/ijms21249682.
   PubMed Web of Science ®Google Scholar
• Huang L, Liu J, Bie C, et al. Advances in cell death - related signaling pathways in acute-on-chronic liver failure. Clin Res Hepatol Gastroenterol. 2022;46(2):101783. doi: 10.1016/j.clinre.2021.101783.
   PubMed Web of Science ®Google Scholar
• Zheng J, Conrad M. The metabolic underpinnings of ferroptosis. Cell Metab. 2020;32(6):920–937. doi: 10.1016/j.cmet.2020.10.011.
   PubMed Web of Science ®Google Scholar
• Yu J, Wang JQ. Research mechanisms of and pharmaceutical treatments for ferroptosis in liver diseases. Biochimie. 2021;180:149–157. doi: 10.1016/j.biochi.2020.11.002.
   PubMed Web of Science ®Google Scholar
• Daher R, Manceau H, Karim Z. Iron metabolism and the role of the iron-regulating hormone hepcidin in health and disease. Presse Med. 2017;46(12 Pt 2):e272–e278. doi: 10.1016/j.lpm.2017.10.006.
   PubMed Web of Science ®Google Scholar
• Lewerenz J, Hewett SJ, Huang Y, et al. The cystine/glutamate antiporter system x(c)(-) in health and disease: from molecular mechanisms to novel therapeutic opportunities. Antioxid Redox Signal. 2013;18(5):522–555. doi: 10.1089/ars.2011.4391.
   PubMed Web of Science ®Google Scholar
• Dixon SJ, Lemberg KM, Lamprecht MR, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 2012;149(5):1060–1072. doi: 10.1016/j.cell.2012.03.042.
   PubMed Web of Science ®Google Scholar
• Lei P, Bai T, Sun Y. Mechanisms of ferroptosis and relations with regulated cell death: a review. Front Physiol. 2019;10:139. doi: 10.3389/fphys.2019.00139.
   PubMed Web of Science ®Google Scholar
• Soula M, Weber RA, Zilka O, et al. Metabolic determinants of cancer cell sensitivity to canonical ferroptosis inducers. Nat Chem Biol. 2020;16(12):1351–1360. doi: 10.1038/s41589-020-0613-y.
   PubMed Web of Science ®Google Scholar
• Kraft VAN, Bezjian CT, Pfeiffer S, et al. GTP cyclohydrolase 1/tetrahydrobiopterin counteract ferroptosis through lipid remodeling. ACS Cent Sci. 2020;6(1):41–53. doi: 10.1021/acscentsci.9b01063.
   PubMed Web of Science ®Google Scholar
• Dodson M, Castro-Portuguez R, Zhang DD. NRF2 plays a critical role in mitigating lipid peroxidation and ferroptosis. Redox Biol. 2019;23:101107. doi: 10.1016/j.redox.2019.101107.
   PubMed Web of Science ®Google Scholar
• Kerins MJ, Ooi A. The roles of NRF2 in modulating cellular iron homeostasis. Antioxid Redox Signal. 2018;29(17):1756–1773. doi: 10.1089/ars.2017.7176.
   PubMed Web of Science ®Google Scholar
• Jung KA, Kwak MK. The Nrf2 system as a potential target for the development of indirect antioxidants. Molecules. 2010;15(10):7266–7291. doi: 10.3390/molecules15107266.
   PubMed Web of Science ®Google Scholar
• Jiang L, Kon N, Li T, et al. Ferroptosis as a p53-mediated activity during tumour suppression. Nature. 2015;520(7545):57–62. doi: 10.1038/nature14344.
   PubMed Web of Science ®Google Scholar
• Xie Y, Zhu S, Song X, et al. The tumor suppressor p53 limits ferroptosis by blocking DPP4 activity. Cell Rep. 2017;20(7):1692–1704. doi: 10.1016/j.celrep.2017.07.055.
   PubMed Web of Science ®Google Scholar
• Wu J, Minikes AM, Gao M, et al. Intercellular interaction dictates cancer cell ferroptosis via NF2-YAP signalling. Nature. 2019;572(7769):402–406. doi: 10.1038/s41586-019-1426-6.
   PubMed Web of Science ®Google Scholar
• Stravitz RT, Lee WM. Acute liver failure. Lancet. 2019;394(10201):869–881. doi: 10.1016/S0140-6736(19)31894-X.
   PubMed Web of Science ®Google Scholar
• Yang WS, SriRamaratnam R, Welsch ME, et al. Regulation of ferroptotic cancer cell death by GPX4. Cell. 2014;156(1-2):317–331. doi: 10.1016/j.cell.2013.12.010.
   PubMed Web of Science ®Google Scholar
• Galluzzi L, Vitale I, Aaronson SA, et al. Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018. Cell Death Differ. 2018;25(3):486–541. doi: 10.1038/s41418-017-0012-4.
   PubMed Web of Science ®Google Scholar
• Chen J, Li X, Ge C, et al. The multifaceted role of ferroptosis in liver disease. Cell Death Differ. 2022;29(3):467–480. doi: 10.1038/s41418-022-00941-0.
   PubMed Web of Science ®Google Scholar
• Liu T, Yang L, Gao H, et al. 3,4-dihydroxyphenylethyl alcohol glycoside reduces acetaminophen-induced acute liver failure in mice by inhibiting hepatocyte ferroptosis and pyroptosis. PeerJ. 2022;10:e13082. doi: 10.7717/peerj.13082.
   PubMed Web of Science ®Google Scholar
• Koppula P, Zhuang L, Gan B. Cystine transporter SLC7A11/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy. Protein Cell. 2021;12(8):599–620. doi: 10.1007/s13238-020-00789-5.
   PubMed Web of Science ®Google Scholar
• Iida Y, Okamoto-Katsuyama M, Maruoka S, et al. Effective ferroptotic small-cell lung cancer cell death from SLC7A11 inhibition by sulforaphane. Oncol Lett. 2021;21(1):71. doi: 10.3892/ol.2020.12332.
   PubMed Web of Science ®Google Scholar
• Xu Y, Li Y, Li J, et al. Ethyl carbamate triggers ferroptosis in liver through inhibiting GSH synthesis and suppressing Nrf2 activation. Redox Biol. 2022;53:102349. doi: 10.1016/j.redox.2022.102349.
   PubMed Web of Science ®Google Scholar
• Liu GZ, Xu XW, Tao SH, et al. HBx facilitates ferroptosis in acute liver failure via EZH2 mediated SLC7A11 suppression. J Biomed Sci. 2021;28(1):67. doi: 10.1186/s12929-021-00762-2.
   PubMed Web of Science ®Google Scholar
• Lin F, Chen W, Zhou J, et al. Mesenchymal stem cells protect against ferroptosis via exosome-mediated stabilization of SLC7A11 in acute liver injury. Cell Death Dis. 2022;13(3):271. doi: 10.1038/s41419-022-04708-w.
   PubMed Web of Science ®Google Scholar
• Wu J, Xue R, Wu M, et al. Nrf2-Mediated ferroptosis inhibition exerts a protective effect on acute-on-chronic liver failure. Oxid Med Cell Longev. 2022;2022:4505513. doi: 10.1155/2022/4505513.
   PubMed Web of Science ®Google Scholar
• Cai X, Hua S, Deng J, et al. Astaxanthin activated the Nrf2/HO-1 pathway to enhance autophagy and inhibit ferroptosis, ameliorating acetaminophen-induced liver injury. ACS Appl Mater Interfaces. 2022;14(38):42887–42903. doi: 10.1021/acsami.2c10506.
   PubMed Web of Science ®Google Scholar
• Yang W, Wang Y, Zhang C, et al. Maresin1 protect against ferroptosis-induced liver injury through ROS inhibition and Nrf2/HO-1/GPX4 activation. Front Pharmacol. 2022;13:865689. doi: 10.3389/fphar.2022.865689.
   PubMed Web of Science ®Google Scholar
• Wang C, Liu T, Tong Y, et al. Ulinastatin protects against acetaminophen-induced liver injury by alleviating ferroptosis via the SIRT1/NRF2/HO-1 pathway. Am J Transl Res. 2021;13(6):6031–6042.
   PubMed Web of Science ®Google Scholar
• Zhao T, Yu Z, Zhou L, et al. Regulating Nrf2-GPx4 axis by bicyclol can prevent ferroptosis in carbon tetrachloride-induced acute liver injury in mice. Cell Death Discov. 2022;8(1):380. doi: 10.1038/s41420-022-01173-4.
   PubMed Web of Science ®Google Scholar
• Dai C, Li H, Wang Y, et al. Inhibition of oxidative stress and ALOX12 and NF-kappaB pathways contribute to the protective effect of baicalein on carbon tetrachloride-induced acute liver injury. Antioxidants. 2021;10(6):976. doi: 10.3390/antiox10060976.
   Web of Science ®Google Scholar
• Zhao S, Huang M, Yan L, et al. Exosomes derived from baicalin-pretreated mesenchymal stem cells alleviate hepatocyte ferroptosis after acute liver injury via the Keap1-NRF2 pathway. Oxid Med Cell Longev. 2022;2022:8287227. doi: 10.1155/2022/8287227.
   PubMed Web of Science ®Google Scholar
• Wu Y, Jiao H, Yue Y, et al. Ubiquitin ligase E3 HUWE1/MULE targets transferrin receptor for degradation and suppresses ferroptosis in acute liver injury. Cell Death Differ. 2022;29(9):1705–1718. doi: 10.1038/s41418-022-00957-6.
   PubMed Web of Science ®Google Scholar
• He P, Hua H, Tian W, et al. Holly (Ilex latifolia Thunb.) polyphenols extracts alleviate hepatic damage by regulating ferroptosis following diquat challenge in a piglet model. Front Nutr. 2020;7:604328. doi: 10.3389/fnut.2020.604328.
   PubMed Web of Science ®Google Scholar
• Huang S, Wang Y, Xie S, et al. Hepatic TGFbetar1 deficiency attenuates lipopolysaccharide/D-galactosamine-induced acute liver failure through inhibiting GSK3beta-Nrf2-mediated hepatocyte apoptosis and ferroptosis. Cell Mol Gastroenterol Hepatol. 2022;13(6):1649–1672. doi: 10.1016/j.jcmgh.2022.02.009.
   PubMed Web of Science ®Google Scholar
• Tak J, Kim YS, Kim TH, et al. Galpha(12) overexpression in hepatocytes by ER stress exacerbates acute liver injury via ROCK1-mediated miR-15a and ALOX12 dysregulation. Theranostics. 2022;12(4):1570–1588. doi: 10.7150/thno.67722.
   PubMed Web of Science ®Google Scholar
• Wei S, Qiu T, Yao X, et al. Arsenic induces pancreatic dysfunction and ferroptosis via mitochondrial ROS-autophagy-lysosomal pathway. J Hazard Mater. 2020;384:121390. doi: 10.1016/j.jhazmat.2019.121390.
   PubMed Web of Science ®Google Scholar
• Marchi S, Giorgi C, Suski JM, et al. Mitochondria-ros crosstalk in the control of cell death and aging. J Signal Transduct. 2012;2012:329635. doi: 10.1155/2012/329635.
   PubMedGoogle Scholar
• Wei L, Zuo Z, Yang Z, et al. Mitochondria damage and ferroptosis involved in Ni-induced hepatotoxicity in mice. Toxicology. 2022;466:153068. doi: 10.1016/j.tox.2021.153068.
   PubMed Web of Science ®Google Scholar
• Niu B, Lei X, Xu Q, et al. Protecting mitochondria via inhibiting VDAC1 oligomerization alleviates ferroptosis in acetaminophen-induced acute liver injury. Cell Biol Toxicol. 2022;38(3):505–530. doi: 10.1007/s10565-021-09624-x.
   PubMed Web of Science ®Google Scholar
• Bai Z, Tao W, Zhou Y, et al. Xiao-Yao-San protects against anti-tuberculosis drug-induced liver injury by regulating Grsf1 in the mitochondrial oxidative stress pathway. Front Pharmacol. 2022;13:948128. doi: 10.3389/fphar.2022.948128.
   PubMed Web of Science ®Google Scholar
• Ji Y, Si W, Zeng J, et al. Niujiaodihuang detoxify decoction inhibits ferroptosis by enhancing glutathione synthesis in acute liver failure models. J Ethnopharmacol. 2021;279:114305. doi: 10.1016/j.jep.2021.114305.
   PubMed Web of Science ®Google Scholar
• Shi H, Yan Y, Yang H, et al. Schisandrin B diet inhibits oxidative stress to reduce ferroptosis and lipid peroxidation to prevent pirarubicin-induced hepatotoxicity. Biomed Res Int. 2022;2022:5623555. doi: 10.1155/2022/5623555.
   PubMed Web of Science ®Google Scholar
• Trivedi PJ, Hubscher SG, Heneghan M, et al. Grand round: autoimmune hepatitis. J Hepatol. 2019;70(4):773–784. doi: 10.1016/j.jhep.2018.11.006.
   PubMed Web of Science ®Google Scholar
• Muratori P, Granito A, Lenzi M, et al. Limitation of the simplified scoring system for the diagnosis of autoimmune hepatitis with acute onset. Liver Int. 2021;41(3):529–534. doi: 10.1111/liv.14778.
   PubMed Web of Science ®Google Scholar
• Mao L, Zhao T, Song Y, et al. The emerging role of ferroptosis in non-cancer liver diseases: hype or increasing hope? Cell Death Dis. 2020;11(7):518. doi: 10.1038/s41419-020-2732-5.
   PubMed Web of Science ®Google Scholar
• Zhu L, Chen D, Zhu Y, et al. GPX4-regulated ferroptosis mediates S100-Induced experimental autoimmune hepatitis associated with the Nrf2/HO-1 signaling pathway. Oxid Med Cell Longev. 2021;2021:6551069. doi: 10.1155/2021/6551069.
   PubMed Web of Science ®Google Scholar
• Manthey J, Shield KD, Rylett M, et al. Global alcohol exposure between 1990 and 2017 and forecasts until 2030: a modelling study. Lancet. 2019;393(10190):2493–2502. doi: 10.1016/S0140-6736(18)32744-2.
   PubMed Web of Science ®Google Scholar
• Ioannou GN, Dominitz JA, Weiss NS, et al. The effect of alcohol consumption on the prevalence of iron overload, iron deficiency, and iron deficiency anemia. Gastroenterology. 2004;126(5):1293–1301. doi: 10.1053/j.gastro.2004.01.020.
   PubMed Web of Science ®Google Scholar
• Li Y, Huang X, Wang J, et al. Regulation of iron homeostasis and related diseases. Mediators Inflamm. 2020;2020:6062094. doi: 10.1155/2020/6062094.
   PubMed Web of Science ®Google Scholar
• Sangkhae V, Nemeth E. Regulation of the iron homeostatic hormone hepcidin. Adv Nutr. 2017;8(1):126–136. doi: 10.3945/an.116.013961.
   PubMed Web of Science ®Google Scholar
• Suzuki M, Fujimoto Y, Suzuki Y, et al. Induction of transferrin receptor by ethanol in rat primary hepatocyte culture. Alcohol Clin Exp Res. 2004;28(8 Suppl Proceedings):98S–105S. doi: 10.1097/01.alc.0000133584.61304.19.
   PubMed Web of Science ®Google Scholar
• Xue M, Tian Y, Sui Y, et al. Protective effect of fucoidan against iron overload and ferroptosis-induced liver injury in rats exposed to alcohol. Biomed Pharmacother. 2022;153:113402. doi: 10.1016/j.biopha.2022.113402.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Zhao S, Fu Y, et al. Computational repositioning of dimethyl fumarate for treating alcoholic liver disease. Cell Death Dis. 2020;11(8):641. doi: 10.1038/s41419-020-02890-3.
   PubMed Web of Science ®Google Scholar
• Mantovani A, Scorletti E, Mosca A, et al. Complications, morbidity and mortality of nonalcoholic fatty liver disease. Metabolism. 2020;111S:154170. doi: 10.1016/j.metabol.2020.154170.
   PubMed Web of Science ®Google Scholar
• Younossi Z, Anstee QM, Marietti M, et al. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol. 2018;15(1):11–20. doi: 10.1038/nrgastro.2017.109.
   PubMed Web of Science ®Google Scholar
• Younossi Z, Tacke F, Arrese M, et al. Global perspectives on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Hepatology. 2019;69(6):2672–2682. doi: 10.1002/hep.30251.
   PubMed Web of Science ®Google Scholar
• Chen Z, Tian R, She Z, et al. Role of oxidative stress in the pathogenesis of nonalcoholic fatty liver disease. Free Radic Biol Med. 2020;152:116–141. doi: 10.1016/j.freeradbiomed.2020.02.025.
   PubMed Web of Science ®Google Scholar
• Loomba R, Friedman SL, Shulman GI. Mechanisms and disease consequences of nonalcoholic fatty liver disease. Cell. 2021;184(10):2537–2564. doi: 10.1016/j.cell.2021.04.015.
   PubMed Web of Science ®Google Scholar
• Dai X, Zhang R, Wang B. Contribution of classification based on ferroptosis-related genes to the heterogeneity of MAFLD. BMC Gastroenterol. 2022;22(1):55. doi: 10.1186/s12876-022-02137-9.
   PubMed Web of Science ®Google Scholar
• Day K, Seale LA, Graham RM, et al. Selenotranscriptome network in non-alcoholic fatty liver disease. Front Nutr. 2021;8:744825. doi: 10.3389/fnut.2021.744825.
   PubMed Web of Science ®Google Scholar
• Liu B, Yi W, Mao X, et al. Enoyl coenzyme a hydratase 1 alleviates nonalcoholic steatohepatitis in mice by suppressing hepatic ferroptosis. Am J Physiol Endocrinol Metab. 2021;320(5):E925–E937. doi: 10.1152/ajpendo.00614.2020.
   PubMed Web of Science ®Google Scholar
• Lu D, Xia Q, Yang Z, et al. ENO3 promoted the progression of NASH by negatively regulating ferroptosis via elevation of GPX4 expression and lipid accumulation. Ann Transl Med. 2021;9(8):661. doi: 10.21037/atm-21-471.
   PubMed Web of Science ®Google Scholar
• Wang X, Ma B, Wen X, et al. Bone morphogenetic protein 4 alleviates nonalcoholic steatohepatitis by inhibiting hepatic ferroptosis. Cell Death Discov. 2022;8(1):234. doi: 10.1038/s41420-022-01011-7.
   PubMed Web of Science ®Google Scholar
• Qi J, Kim JW, Zhou Z, et al. Ferroptosis affects the progression of nonalcoholic steatohepatitis via the modulation of lipid peroxidation-mediated cell death in mice. Am J Pathol. 2020;190(1):68–81. doi: 10.1016/j.ajpath.2019.09.011.
   PubMed Web of Science ®Google Scholar
• Gao G, Xie Z, Li EW, et al. Dehydroabietic acid improves nonalcoholic fatty liver disease through activating the Keap1/Nrf2-ARE signaling pathway to reduce ferroptosis. J Nat Med. 2021;75(3):540–552. doi: 10.1007/s11418-021-01491-4.
   PubMed Web of Science ®Google Scholar
• Zhu Z, Zhang Y, Huang X, et al. Thymosin beta 4 alleviates non-alcoholic fatty liver by inhibiting ferroptosis via up-regulation of GPX4. Eur J Pharmacol. 2021;908:174351. doi: 10.1016/j.ejphar.2021.174351.
   PubMed Web of Science ®Google Scholar
• Tsurusaki S, Tsuchiya Y, Koumura T, et al. Hepatic ferroptosis plays an important role as the trigger for initiating inflammation in nonalcoholic steatohepatitis. Cell Death Dis. 2019;10(6):449. doi: 10.1038/s41419-019-1678-y.
   PubMed Web of Science ®Google Scholar
• Vetuschi A, Cappariello A, Onori P, et al. Ferroptosis resistance cooperates with cellular senescence in the overt stage of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. Eur J Histochem. 2022;66(3):3391. doi: 10.4081/ejh.2022.3391.
   Web of Science ®Google Scholar
• Wei S, Qiu T, Wang N, et al. Ferroptosis mediated by the interaction between Mfn2 and IREalpha promotes arsenic-induced nonalcoholic steatohepatitis. Environ Res. 2020;188:109824. doi: 10.1016/j.envres.2020.109824.
   PubMed Web of Science ®Google Scholar
• Yang Y, Chen J, Gao Q, et al. Study on the attenuated effect of ginkgolide B on ferroptosis in high fat diet induced nonalcoholic fatty liver disease. Toxicology. 2020;445:152599. doi: 10.1016/j.tox.2020.152599.
   PubMed Web of Science ®Google Scholar
• Bataller R, Brenner DA. Liver fibrosis. J Clin Invest. 2005;115(2):209–218. doi: 10.1172/JCI24282.
   PubMed Web of Science ®Google Scholar
• Sebastiani G, Gkouvatsos K, Pantopoulos K. Chronic hepatitis C and liver fibrosis. World J Gastroenterol. 2014;20(32):11033–11053. doi: 10.3748/wjg.v20.i32.11033.
   PubMed Web of Science ®Google Scholar
• Du K, Oh SH, Dutta RK, et al. Inhibiting xCT/SLC7A11 induces ferroptosis of myofibroblastic hepatic stellate cells but exacerbates chronic liver injury. Liver Int. 2021;41(9):2214–2227. doi: 10.1111/liv.14945.
   PubMed Web of Science ®Google Scholar
• Zhu Y, Zhang C, Huang M, et al. TRIM26 induces ferroptosis to inhibit hepatic stellate cell activation and mitigate liver fibrosis through mediating SLC7A11 ubiquitination. Front Cell Dev Biol. 2021;9:644901. doi: 10.3389/fcell.2021.644901.
   PubMed Web of Science ®Google Scholar
• Zhang Q, Qu Y, Zhang Q, et al. Exosomes derived from hepatitis B virus-infected hepatocytes promote liver fibrosis via miR-222/TFRC axis. Cell Biol Toxicol. 2023;39(2):467–481. doi: 10.1007/s10565-021-09684-z.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Guo M, Shen M, et al. The BRD7-P53-SLC25A28 axis regulates ferroptosis in hepatic stellate cells. Redox Biol. 2020;36:101619. doi: 10.1016/j.redox.2020.101619.
   PubMed Web of Science ®Google Scholar
• Shen M, Guo M, Li Y, et al. m(6)a methylation is required for dihydroartemisinin to alleviate liver fibrosis by inducing ferroptosis in hepatic stellate cells. Free Radic Biol Med. 2022;182:246–259. doi: 10.1016/j.freeradbiomed.2022.02.028.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Wang X, Wang Z, et al. Dihydroartemisinin alleviates hepatic fibrosis through inducing ferroptosis in hepatic stellate cells. Biofactors. 2021;47(5):801–818. doi: 10.1002/biof.1764.
   PubMed Web of Science ®Google Scholar
• Que R, Cao M, Dai Y, et al. Decursin ameliorates carbon-tetrachloride-induced liver fibrosis by facilitating ferroptosis of hepatic stellate cells. Biochem Cell Biol. 2022;100(5):378–386. doi: 10.1139/bcb-2022-0027.
   PubMedGoogle Scholar
• Yi J, Wu S, Tan S, et al. Berberine alleviates liver fibrosis through inducing ferrous redox to activate ROS-mediated hepatic stellate cells ferroptosis. Cell Death Discov. 2021;7(1):374. doi: 10.1038/s41420-021-00768-7.
   PubMed Web of Science ®Google Scholar
• Kuo CY, Chiu V, Hsieh PC, et al. Chrysophanol attenuates hepatitis B virus X protein-induced hepatic stellate cell fibrosis by regulating endoplasmic reticulum stress and ferroptosis. J Pharmacol Sci. 2020;144(3):172–182. doi: 10.1016/j.jphs.2020.07.014.
   PubMed Web of Science ®Google Scholar
• Li L, Wang K, Jia R, et al. Ferroportin-dependent ferroptosis induced by ellagic acid retards liver fibrosis by impairing the SNARE complexes formation. Redox Biol. 2022;56:102435. doi: 10.1016/j.redox.2022.102435.
   PubMed Web of Science ®Google Scholar
• Chutvanichkul B, Vattanaviboon P, Mas-Oodi S, et al. Labile iron Pool as a parameter to monitor iron overload and oxidative stress status in beta-thalassemic erythrocytes. Cytometry B Clin Cytom. 2018;94(4):631–636. doi: 10.1002/cyto.b.21633.
   PubMed Web of Science ®Google Scholar
• Cabantchik ZI. Labile iron in cells and body fluids: physiology, pathology, and pharmacology. Front Pharmacol. 2014;5:45. doi: 10.3389/fphar.2014.00045.
   PubMed Web of Science ®Google Scholar
• Nakamura T, Naguro I, Ichijo H. Iron homeostasis and iron-regulated ROS in cell death, senescence and human diseases. Biochim Biophys Acta Gen Subj. 2019;1863(9):1398–1409. doi: 10.1016/j.bbagen.2019.06.010.
   PubMed Web of Science ®Google Scholar
• Moon JH, Park SH, Oh KC, et al. [Association of hepatic iron deposition and serum iron indices with hepatic inflammation and fibrosis stage in nonalcoholic fatty liver disease]. Korean J Gastroenterol. 2006;47(6):432–439.
   PubMedGoogle Scholar
• Ramm GA, Ruddell RG. Iron homeostasis, hepatocellular injury, and fibrogenesis in hemochromatosis: the role of inflammation in a noninflammatory liver disease. Semin Liver Dis. 2010;30(3):271–287. doi: 10.1055/s-0030-1255356.
   PubMed Web of Science ®Google Scholar
• Yang L, Wang H, Yang X, et al. Auranofin mitigates systemic iron overload and induces ferroptosis via distinct mechanisms. Signal Transduct Target Ther. 2020;5(1):138. doi: 10.1038/s41392-020-00253-0.
   PubMed Web of Science ®Google Scholar
• Xing G, Meng L, Cao S, et al. PPARalpha alleviates iron overload-induced ferroptosis in mouse liver. EMBO Rep. 2022;23(8):e52280. doi: 10.15252/embr.202052280.
   PubMed Web of Science ®Google Scholar
• Salama SA, Abdel-Bakky MS, Mohamed AA. Upregulation of Nrf2 signaling and suppression of ferroptosis and NF-kappaB pathway by leonurine attenuate iron overload-induced hepatotoxicity. Chem Biol Interact. 2022;356:109875. doi: 10.1016/j.cbi.2022.109875.
   PubMed Web of Science ®Google Scholar
• Wu S, Yang J, Sun G, et al. Macrophage extracellular traps aggravate iron overload-related liver ischaemia/reperfusion injury. Br J Pharmacol. 2021;178(18):3783–3796. doi: 10.1111/bph.15518.
   PubMed Web of Science ®Google Scholar
• Li X, Wu L, Tian X, et al. miR-29a-3p in exosomes from heme oxygenase-1 modified bone marrow mesenchymal stem cells alleviates steatotic liver ischemia-reperfusion injury in rats by suppressing ferroptosis via iron responsive element binding protein 2. Oxid Med Cell Longev. 2022;2022:6520789. doi: 10.1155/2022/6520789.
   PubMed Web of Science ®Google Scholar
• Chen Y, Zhu S, Chen Z, et al. Gingerenone a alleviates ferroptosis in secondary liver injury in colitis mice via activating Nrf2-Gpx4 signaling pathway. J Agric Food Chem. 2022;70(39):12525–12534. doi: 10.1021/acs.jafc.2c05262.
   PubMed Web of Science ®Google Scholar
• Song JX, An JR, Chen Q, et al. Liraglutide attenuates hepatic iron levels and ferroptosis in db/db mice. Bioengineered. 2022;13(4):8334–8348. doi: 10.1080/21655979.2022.2051858.
   PubMed Web of Science ®Google Scholar
• Yuan Y, Yucai L, Lu L, et al. Acrylamide induces ferroptosis in HSC-T6 cells by causing antioxidant imbalance of the XCT-GSH-GPX4 signaling and mitochondrial dysfunction. Toxicol Lett. 2022;368:24–32. doi: 10.1016/j.toxlet.2022.08.007.
   PubMed Web of Science ®Google Scholar
• Schnellmann JG, Pumford NR, Kusewitt DF, et al. Deferoxamine delays the development of the hepatotoxicity of acetaminophen in mice. Toxicol Lett. 1999;106(1):79–88. doi: 10.1016/s0378-4274(99)00021-1.
   PubMed Web of Science ®Google Scholar
• Shah R, Shah A, Badawy SM. An evaluation of deferiprone as twice-a-day tablets or in combination therapy for the treatment of transfusional iron overload in thalassemia syndromes. Expert Rev Hematol. 2023;16(2):81–94. doi: 10.1080/17474086.2023.2178409.
   PubMed Web of Science ®Google Scholar
• Carlson BA, Tobe R, Yefremova E, et al. Glutathione peroxidase 4 and vitamin E cooperatively prevent hepatocellular degeneration. Redox Biol. 2016;9:22–31. doi: 10.1016/j.redox.2016.05.003.
   PubMed Web of Science ®Google Scholar
• Scheen AJ, Lefebvre PJ. Troglitazone: antihyperglycemic activity and potential role in the treatment of type 2 diabetes. Diabetes Care. 1999;22(9):1568–1577. doi: 10.2337/diacare.22.9.1568.
   PubMed Web of Science ®Google Scholar
• Zhai Z, Zou P, Liu F, et al. Ferroptosis is a potential novel diagnostic and therapeutic target for patients with cardiomyopathy. Front Cell Dev Biol. 2021;9:649045. doi: 10.3389/fcell.2021.649045.
   PubMed Web of Science ®Google Scholar
• Louandre C, Ezzoukhry Z, Godin C, et al. Iron-dependent cell death of hepatocellular carcinoma cells exposed to sorafenib. Int J Cancer. 2013;133(7):1732–1742. doi: 10.1002/ijc.28159.
   PubMed Web of Science ®Google Scholar
• Kong FH, Ye QF, Miao XY, et al. Current status of sorafenib nanoparticle delivery systems in the treatment of hepatocellular carcinoma. Theranostics. 2021;11(11):5464–5490. doi: 10.7150/thno.54822.
   PubMed Web of Science ®Google Scholar
• Chen LD, Wu RH, Huang YZ, et al. The role of ferroptosis in chronic intermittent hypoxia-induced liver injury in rats. Sleep Breath. 2020;24(4):1767–1773. doi: 10.1007/s11325-020-02091-4.
   PubMed Web of Science ®Google Scholar
• Sutti S, Jindal A, Locatelli I, et al. Adaptive immune responses triggered by oxidative stress contribute to hepatic inflammation in NASH. Hepatology. 2014;59(3):886–897. doi: 10.1002/hep.26749.
   PubMed Web of Science ®Google Scholar